Nasdaq

Masimo Announces FDA Clearance of Radius PCG™ for the Root® Patient Monitoring and Connectivity Platform

IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance.
Nasdaq

Masimo Announces Pathway™, a Newborn Oxygenation Visualization Mode for the Root® Patient Monitoring and Connectivity Platform

The International Liaison Committee on Resuscitation (American Heart Association) has developed treatment recommendations outlining time-based SpO2 targets that reflect a healthy newborn’s oxygenation ...
Business Wire

Masimo Launches Dual SET ® Pulse Oximetry

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced Dual SET ® Pulse Oximetry for Root ®, a highly versatile patient monitoring and connectivity hub. The first application ...
Business Wire

Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, ...
Seeking Alpha

Masimo Reports First Quarter 2025 Results

Masimo (Nasdaq: MASI) is a global technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, ...